Non-Transfusion Dependent Beta-Thalassemia (NTDT) Clinical Trials in Kota Kinabalu, Sabah

A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body